{"id":89867,"date":"2026-01-27T10:32:07","date_gmt":"2026-01-27T10:32:07","guid":{"rendered":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/indias-path-to-universal-health-care-outlined-in-lancet-paper-ahead-of-budget-2026-bw-healthcare-world\/"},"modified":"2026-01-27T10:32:07","modified_gmt":"2026-01-27T10:32:07","slug":"indias-path-to-universal-health-care-outlined-in-lancet-paper-ahead-of-budget-2026-bw-healthcare-world","status":"publish","type":"post","link":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/indias-path-to-universal-health-care-outlined-in-lancet-paper-ahead-of-budget-2026-bw-healthcare-world\/","title":{"rendered":"India’s Path To Universal Health Care Outlined In Lancet Paper Ahead Of Budget 2026 – BW Healthcare World"},"content":{"rendered":"

A recent paper published in The Lancet has outlined a roadmap for India to achieve universal health care by 2030, with a focus on the upcoming Budget 2026. The paper, titled “India’s path to universal health coverage: a call to action,” highlights the country’s progress towards achieving universal health care and identifies key areas that require attention and investment.<\/p>\n

The authors of the paper note that India has made significant strides in improving health outcomes in recent years, with a decline in infant and maternal mortality rates, and an increase in life expectancy. However, despite these gains, the country still faces significant health challenges, including a high burden of non-communicable diseases, inadequate healthcare infrastructure, and a shortage of healthcare professionals.<\/p>\n

To address these challenges, the paper recommends that the Indian government increase its investment in healthcare to at least 2.5% of the country’s GDP by 2025, with a focus on strengthening primary healthcare, improving healthcare infrastructure, and enhancing the skills of healthcare professionals. The authors also emphasize the need for a more equitable and inclusive healthcare system, with a focus on reaching marginalized and vulnerable populations.<\/p>\n

The paper identifies several key areas that require attention and investment in the upcoming Budget 2026, including:<\/p>\n

    \n
  1. Strengthening primary healthcare<\/strong>: The authors recommend increasing investment in primary healthcare, including the expansion of health and wellness centers, and the deployment of more community health workers.<\/li>\n
  2. Improving healthcare infrastructure<\/strong>: The paper highlights the need for significant investment in healthcare infrastructure, including the construction of new hospitals, the upgrading of existing facilities, and the procurement of medical equipment.<\/li>\n
  3. Enhancing the skills of healthcare professionals<\/strong>: The authors recommend increasing investment in the training and development of healthcare professionals, including doctors, nurses, and community health workers.<\/li>\n
  4. Expanding health insurance coverage<\/strong>: The paper emphasizes the need to expand health insurance coverage to all citizens, with a focus on marginalized and vulnerable populations.<\/li>\n<\/ol>\n

    Overall, the paper provides a comprehensive roadmap for India to achieve universal health care by 2030, with a focus on strengthening primary healthcare, improving healthcare infrastructure, and enhancing the skills of healthcare professionals. The authors emphasize the need for significant investment in healthcare in the upcoming Budget 2026, and highlight the importance of a more equitable and inclusive healthcare system that reaches all citizens, regardless of their income or social status.<\/p>\n","protected":false},"excerpt":{"rendered":"

    A recent paper published in The Lancet has outlined a roadmap for India to achieve universal health care by 2030, with a focus on the upcoming Budget 2026. The paper, titled “India’s path to universal health coverage: a call to action,” highlights the country’s progress towards achieving universal health care and identifies key areas that […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-89867","post","type-post","status-publish","format-standard","hentry","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89876,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/29\/hyderabad-to-witness-global-voices-one-vision-international-health-dialogue-2026-hosted-by-apollo-hospitals\/","url_meta":{"origin":89867,"position":0},"title":"Hyderabad to Witness ‘Global Voices, One Vision’ International Health Dialogue 2026, Hosted by Apollo Hospitals","author":"Team Small News","date":"January 29, 2026","format":false,"excerpt":"The 13th edition of the International Health Dialogue (IHD) will be hosted by Apollo Hospitals in Hyderabad on January 30 and 31, 2026. The event will bring together global leaders to discuss patient safety, healthcare innovation, and system-wide transformation. The theme of IHD 2026, \"Global Voices. One Vision,\" emphasizes the\u2026","rel":"","context":"In "Apollo Hospital"","block_context":{"text":"Apollo Hospital","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/apollo-hospital\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89800,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/14\/apollo-hospitals-managing-director-denies-rumors-of-a-family-feud-citing-the-demerger-as-a-deliberate-business-strategy\/","url_meta":{"origin":89867,"position":1},"title":"Apollo Hospitals Managing Director denies rumors of a family feud, citing the demerger as a deliberate business strategy.","author":"Team Small News","date":"January 14, 2026","format":false,"excerpt":"Apollo Hospitals Enterprise is undergoing a significant restructuring process, spinning off its pharmacy and digital health businesses into a separate entity called Apollo HealthCo. Managing Director Suneeta Reddy has clarified that this decision is driven by a desire to enhance shareholder value and is not related to family differences or\u2026","rel":"","context":"In "Apollo Hospital"","block_context":{"text":"Apollo Hospital","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/apollo-hospital\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89869,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/zydus-lifesciences-introduces-indias-first-biosimilar-version-of-nivolumab-a-global-breakthrough\/","url_meta":{"origin":89867,"position":2},"title":"Zydus Lifesciences introduces India’s first biosimilar version of Nivolumab, a global breakthrough.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Zydus Lifesciences, a leading life sciences company, has launched the world's first biosimilar of nivolumab in India under the brand name Tishtha. This milestone marks a significant expansion of patient access to cutting-edge cancer therapies, particularly in the field of Immuno-Oncology. Tishtha will be available in two dosage strengths, 100\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89842,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/sun-pharma-receives-dcgi-approval-for-generic-version-of-wegovy-plans-march-release-ahead-of-semaglutide-patent-expiration\/","url_meta":{"origin":89867,"position":3},"title":"Sun Pharma receives DCGI approval for generic version of Wegovy, plans March release ahead of Semaglutide patent expiration.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to launch a generic version of Novo Nordisk's Wegovy, a medication used to treat obesity. The approval comes as the patent for the active ingredient, semaglutide, is set to expire in March 2023. Wegovy, which contains\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":89907,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/02\/06\/piramal-critical-care-collaborates-with-blue-zone-to-launch-innovative-waste-anaesthetic-gas-recycling-initiative\/","url_meta":{"origin":89867,"position":4},"title":"Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.","author":"Team Small News","date":"February 6, 2026","format":false,"excerpt":"Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This innovative collaboration seeks to address the significant problem of anaesthetic gas waste, which contributes\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Piramal-Healthcare.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":89763,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/07\/dr-reddys-introduces-hevaxin-indias-inaugural-hepatitis-e-vaccine-approved-by-the-dcgi-specifically-designed-for-adult-use\/","url_meta":{"origin":89867,"position":5},"title":"Dr. Reddy’s introduces Hevaxin, India’s inaugural Hepatitis E vaccine approved by the DCGI, specifically designed for adult use.","author":"Team Small News","date":"January 7, 2026","format":false,"excerpt":"Dr. Reddy's Laboratories has launched Hevaxin, a novel recombinant vaccine for the prevention of Hepatitis E virus (HEV) infection in India. This vaccine is the only one approved by the Drug Controller General of India (DCGI) for active immunization against HEV infection in adults aged 18 to 65 years. Clinical\u2026","rel":"","context":"In "Dr Reddy's"","block_context":{"text":"Dr Reddy's","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/dr-reddys\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89867"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89867\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}